Australia markets closed

Kintara Therapeutics, Inc. (KTRA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.2550-0.0230 (-8.27%)
At close: 04:00PM EDT
0.2598 +0.00 (+1.88%)
After hours: 07:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.2780
Open0.2750
Bid0.2505 x 1200
Ask0.2598 x 800
Day's range0.2500 - 0.2879
52-week range0.1410 - 2.0700
Volume967,968
Avg. volume4,279,980
Market cap16.711M
Beta (5Y monthly)1.72
PE ratio (TTM)N/A
EPS (TTM)-0.6430
Earnings date27 Sept 2022 - 03 Oct 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est3.17
  • PR Newswire

    Kintara Therapeutics to Present at the Alliance Global Partners Summer Healthcare Conference

    Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that President and CEO Robert E. Hoffman will present a corporate overview at the Alliance Global Partners Summer Healthcare Conference. The conference is being held virtually on June 21 – 22, 2022.

  • PR Newswire

    Kintara Therapeutics Granted Fast Track Designation from the FDA for VAL-083 for Newly-Diagnosed Glioblastoma

    Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kintara's VAL-083 for the treatment of patients with newly-diagnosed unmethylated glioblastoma (GBM).

  • PR Newswire

    Kintara Therapeutics to Present at the JMP Securities Life Sciences Conference

    Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that President and CEO Robert E. Hoffman will present a corporate overview at the JMP Securities Life Sciences Conference. The conference is being held on June 15 – 16, 2022 at the Lotte New York Palace Hotel.